nimesulide has been researched along with kainic acid in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Ajamieh, HH; Candelario-Jalil, E; León Fernández, OS; Martínez, G; Sam, S | 1 |
| Kunz, T; Oliw, EH | 1 |
| Candelario-Jalil, E; Sonia León, O | 1 |
| Bishnoi, M; Kulkarni, SK; Kumar, A; Patil, CS | 1 |
5 other study(ies) available for nimesulide and kainic acid
| Article | Year |
|---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Nimesulide limits kainate-induced oxidative damage in the rat hippocampus.
Topics: Animals; Behavior, Animal; Cyclooxygenase Inhibitors; Glutathione; Hippocampus; Kainic Acid; Lipid Peroxidation; Male; Oxidative Stress; Rats; Rats, Sprague-Dawley; Sulfonamides | 2000 |
Nimesulide aggravates kainic acid-induced seizures in the rat.
Topics: Animals; Behavior, Animal; Blotting, Northern; Cerebral Cortex; Cyclooxygenase Inhibitors; Drug Combinations; Drug Interactions; Excitatory Amino Acid Agonists; Hippocampus; In Situ Hybridization; Injections, Intraperitoneal; Kainic Acid; Male; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; Seizures; Sulfonamides; Time Factors | 2001 |
Effects of nimesulide on kainate-induced in vitro oxidative damage in rat brain homogenates.
Topics: Animals; Brain; Cyclooxygenase Inhibitors; In Vitro Techniques; Kainic Acid; Lipid Peroxidation; Male; Malondialdehyde; Oxidative Stress; Rats; Rats, Sprague-Dawley; Sulfonamides | 2003 |
Co-administration of acetyl-11-keto-beta-boswellic acid, a specific 5-lipoxygenase inhibitor, potentiates the protective effect of COX-2 inhibitors in kainic acid-induced neurotoxicity in mice.
Topics: Administration, Oral; Animals; Antinematodal Agents; Brain; Catalase; Cyclooxygenase 2 Inhibitors; Drug Synergism; Drug Therapy, Combination; Epilepsy, Tonic-Clonic; Glutathione; Indomethacin; Injections, Intraperitoneal; Kainic Acid; Lactones; Lipid Peroxidation; Lipoxygenase Inhibitors; Male; Mice; Mice, Inbred Strains; Nitric Oxide; Peroxidase; Sulfonamides; Sulfones; Triterpenes | 2007 |